# Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary

> **NCT00626873** · PHASE1 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 67 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Definity
- **OTHER:** medical chart review

## Key facts

- **NCT ID:** NCT00626873
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2017-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626873, "Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00626873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*